The FDA removed tirzepatide from the Drug Shortage List in December 2024 and semaglutide in February 2025, eliminating the primary statutory basis the shortage exemption under the Federal Food, Drug, and Cosmetic Act that had allowed commercial-scale compounding
Handling Retatrutide in a Research Setting This section describes the laboratory handling of retatrutide reference material as it is documented in published peptide research protocols
According to the drugs prescribing information, the amount of weight you may lose while taking phentermine varies from study to study
They will assess your body weight, body mass index, blood sugar levels, levels of glycated hemoglobin (HbA1c), and medical history to create a customized treatment plan for you
The Alzheimer's Association will provide updates as soon as trial results are released, helping you understand what the findings mean and how to discuss them with your health care team
See If You Qualify Common questions about compounded tirzepatide treatment.